156 related articles for article (PubMed ID: 38058849)
21. Method comparison of four clinically available assays for serum free light chain analysis.
Fleming CKA; Swarttouw T; de Kat Angelino CM; Jacobs JFM; Russcher H
Clin Chem Lab Med; 2019 Dec; 58(1):85-94. PubMed ID: 31730518
[TBL] [Abstract][Full Text] [Related]
22. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
23. A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Samson MH; Møller HJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740597
[TBL] [Abstract][Full Text] [Related]
24. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies.
Lee WS; Singh G
J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440
[TBL] [Abstract][Full Text] [Related]
25. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
[TBL] [Abstract][Full Text] [Related]
26. Use of Clinical Decision Support to Improve the Laboratory Evaluation of Monoclonal Gammopathies.
Pearson DS; McEvoy DS; Murali MR; Dighe AS
Am J Clin Pathol; 2023 Feb; 159(2):192-204. PubMed ID: 36622340
[TBL] [Abstract][Full Text] [Related]
27. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
Singh G
J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease.
Yang Y; Han X; Zheng G; Cai Z
Health Sci Rep; 2019 Apr; 2(4):e113. PubMed ID: 31049418
[TBL] [Abstract][Full Text] [Related]
29. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
Smith J; Raines G; Schneider HG
Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
[TBL] [Abstract][Full Text] [Related]
30. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
31. Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies.
Harding SJ; Mead GP; Bradwell AR; Berard AM
Clin Chem Lab Med; 2009; 47(3):302-4. PubMed ID: 19676141
[TBL] [Abstract][Full Text] [Related]
32. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
[TBL] [Abstract][Full Text] [Related]
33. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
34. Understanding the Constraints and Optimization of Serum Immunofixation Electrophoresis and Serum Free Light Chains for Detecting Monoclonal Proteins: A Single-Center Experience.
Shastri M; Malhotra P; Kaur H; Aggarwal R
J Lab Physicians; 2023 Dec; 15(4):518-523. PubMed ID: 37780881
[No Abstract] [Full Text] [Related]
35. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of abnormal serum free light chain ratio: diagnostic confusion or underlying monoclonality?
Cho SY; Nam YS; Yoon HJ; Lee HJ; Park TS
Clin Lab; 2013; 59(11-12):1419-22. PubMed ID: 24409680
[TBL] [Abstract][Full Text] [Related]
38. Serum free light chain analysis: persisting limitations with new kids on the block.
Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
[TBL] [Abstract][Full Text] [Related]
39. An Analysis of M-protein in Plasma cell Dyscrasia Patients Identifies that IgG Lambda Subtype is More Commonly Associated with Normal Serum Free Light Chain (SFLC) Ratio.
Singh MK; Paswan V; Dwivedi S; Gupta R; Rahman K; Chandra D; Yadav S; Gupta A; Kashyap R; Nityanand S
Indian J Clin Biochem; 2022 Oct; 37(4):466-472. PubMed ID: 36262785
[TBL] [Abstract][Full Text] [Related]
40. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
